Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24)
Authors:
- Kakuya NiihataKNKakuya Niihata
- Diabetes Distress and Care Registry at Tenri Study GroupDGDiabetes Distress and Care Registry at Tenri Study Group
- Hitoshi IshiiHIHitoshi Ishii
- 13 July 2023
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (12) , 1643-1650
Abstract
Aims The aim of this cohort study was to evaluate the association between urinary levels of C-megalin, a full-length form of megalin, and kidney dysfunction progression and its dependence on the urinary albumin-creatinine ratio (UACR) in individuals with diabetes. Methods We enrolled 1,547 individuals with diabetes who visited the ambulatory clinic at Tenri Hospital, a regional tertiary-care hospital in Tenri City, Nara Prefecture, Japan, with an estimated glomerular filtration (eGFR) of ≥ 30 mL/min/1.73 m2. The hazard ratio (HR) and 95% confidence interval (CI) were estimated using Cox proportional hazard models to examine the association between urinary C-megalin levels and eGFR decline by ≥ 40% from baseline. Results Urinary C-megalin level was not associated with ≥ 40% eGFR decline in an age-, sex-, eGFR-, systolic blood pressure-, hemoglobin-, and UACR-adjusted model in the 1,547 patients enrolled in the study. However, urinary C-megalin levels were associated with a ≥ 40% decline in eGFR when accounting for the relationship between urinary C-megalin levels and UACR in the model. This association was UACR-dependent. Conclusions High urinary C-megalin levels were associated with progressive kidney dysfunction in individuals with diabetes, and this association was attenuated by high UACRs.Keywords
Funding Information
- Manpei Suzuki Diabetes Foundation
- Japan Society for the Promotion of Science (25460641/16K08897)
This publication has 18 references indexed in Scilit:
- Megalin Blockade with Cilastatin Suppresses Drug-Induced NephrotoxicityJournal of the American Society of Nephrology, 2017
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014JAMA, 2016
- Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human diseaseKidney International, 2016
- Serum High-Sensitivity C-Reactive Protein Levels Are Associated With High Risk of Development, Not Progression, of Diabetic Nephropathy Among Japanese Type 2 Diabetic Patients: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT7])Diabetes Care, 2014
- Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the KidneyJournal of the American Society of Nephrology, 2012
- Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 DiabetesDiabetes Care, 2012
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- The Molecular Interactions between Filtered Proteins and Proximal Tubular Cells in ProteinuriaNephron Experimental Nephrology, 2008
- Role of Megalin in Endocytosis of Advanced Glycation End ProductsJournal of the American Society of Nephrology, 2003
- Megalin and cubilin: synergistic endocytic receptors in renal proximal tubuleAmerican Journal of Physiology-Renal Physiology, 2001